CORE1: Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).

被引：0
|
作者：
Rixe, Olivier [1 ]
Castonguay, Vincent [2 ]
Conter, Henry [3 ]
Chalas, Eva [4 ]
Desai, Pratibha
Squillante, Christian [5 ]
MacDonald, Lisa A. [6 ]
Conlon, Rebekah [6 ]
Bramhecha, Yogesh [6 ]
Hirsch, Heather [6 ]
Graff, Jeremy R. [6 ]
Fiset, Stephan [7 ]
机构：
[1] Quantum Santa Fe, Santa Fe, NM USA
[2] Univ Laval, CRCHU Quebec, Quebec City, PQ, Canada
[3] William Osler Hlth Syst, Brampton, ON, Canada
[4] NYU Langone Hosp, Perlmutter Canc Ctr, Mineola, NY USA
[5] Allina Hlth, Minneapolis, MN USA
[6] IMV Inc, Dartmouth, NS, Canada
[7] IMV Inc, Quebec City, PQ, Canada
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT036
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] CORE1: Phase 2, Single Arm Study of CG0070 Combined with Pembrolizumab in Patients with Non Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
    Steinberg, Gary D.
    Li, Roger
    Lamm, Donald
    Uchio, Edward
    Packiam, Vignesh
    Kamat, Ashish
    McAdory, John
    Grandi, Paola
    Kim, Jee-Hyun
    Burke, James
    MOLECULAR THERAPY, 2021, 29 (04) : 319 - 319
  • [2] CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Uchio, Ed
    Packiam, Vignesh
    Kamat, Ashish
    Chisamore, Michael
    McAdory, John
    Grandi, Paola
    Kim, Jee-Hyun
    Burke, James
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A1005 - A1005
  • [3] CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Uchio, Ed M.
    Shah, Paras
    Kamat, Ashish M.
    Hnat, Nataliya
    Chisamore, Michael J.
    Grandi, Paola
    Burke, James
    JOURNAL OF UROLOGY, 2022, 207 (05): : E927 - E927
  • [4] CORE1: Phase 2 single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Steinberg, G. S.
    Uchio, E. U.
    Lamm, D. L.
    Shah, P. S.
    Kamat, A. K.
    Trinity, B.
    Packiam, V.
    Chisamore, M. C.
    Mcadory, J.
    Grandi, P.
    Hnat, N.
    Burke, J.
    EUROPEAN UROLOGY, 2023, 83 : S603 - S603
  • [5] CORE1: PHASE 2 SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Uchio, Edward M.
    Lamm, Donald
    Shah, Paras
    Kamat, Ashish M.
    Bivalacqua, Trinity J.
    Packiam, Vignesh
    Chisamore, Michael J.
    Mcadory, John
    Grandi, Paola
    Hnat, Nataliya
    Burke, James
    JOURNAL OF UROLOGY, 2023, 209 : E408 - E409
  • [6] CORE1: Phase 2, single-arm study of CG0070 combined with pembrolizumab in patients with nonmuscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG).
    Li, Roger
    Steinberg, Gary D.
    Uchio, Edward M.
    Lamm, Donald L.
    Shah, Paras
    Kamat, Ashish M.
    Bivalacqua, Trinity
    Packiam, Vignesh T.
    Chisamore, Michael Jon
    McAdory, John
    Grandi, Paola
    Hnat, Nataliya
    Burke, James
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NONMUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Uchio, Edward
    Lamm, Donald
    Paras, Shah
    Kamat, Ashish
    Bivalacqua, Trinity
    Packiam, Vignesh
    Chisamore, Michael
    McAdory, John
    Grandi, Paola
    Hnat, Nataliya
    Burke, James
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A696 - A696
  • [8] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Uchio, Edward M.
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Kamat, Ashish
    Packiam, Vignesh
    Anderson, Paul
    Ku, Ja Hyeon
    Chisamore, Michael
    McAdory, John
    Hnat, Nataliya
    Kim, Jee-Hyun
    Grandi, Paola
    Burke, James
    CANCER SCIENCE, 2023, 114 : 1587 - 1587
  • [9] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Uchio, E.
    Steinberg, G. D.
    Shore, N.
    Anderson, P. D.
    Ben, T.
    Kamat, A.
    Keel, M.
    Packiam, V.
    McAdory, J.
    Kim, J. H.
    Chisamore, M.
    Grandi, P.
    Burke, J.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A130 - A130
  • [10] A phase 3, single-arm study of CG0070 in subjects with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
    Uchio, Ed
    Lamm, Donald
    Shore, Neil
    Bivalacqua, Trinity
    Kamat, Ashish
    Tyson, Mark
    Anderson, Paul
    Grandi, Paola
    Burke, James
    CANCER RESEARCH, 2022, 82 (12)
12345